Abstract:
Release Date: June 15, 2009
Expiration Date: June 30, 2010
Estimated Time to Complete Activity: 1 hour
Sponsors:
This activity is jointly sponsored by Postgraduate Institute for Medicine and IMPACt, Inc.
Contact Postgraduate Institute for Medicine
Commercial Support:
This activity is supported by an educational grant from Eli Lilly and Company.
Description:
”Virtual Breast Tumor Board: Metastatic Cases” is a case-based discussion that focuses on current issues and changing dynamics in the treatment of patients with advanced breast cancer. The panel of experts will discuss the most appropriate management options for the cases and emphasize a multidisciplinary team approach to treatment.
Learning Objectives:
Upon completion of this activity, participants will be able to:
1. Outline evidence-based therapy recommendations for the cases presented
2. Describe newly reported clinical studies and results of first-line treatment regimens for patients with recurrent or metastatic breast cancer (MBC)
3. Describe the role of targeted therapies in recurrent and MBC
4. Discuss the indications and contraindications for surgery and radiation in recurrent and MBC
5. Describe strategies for 2nd line treatment of MBC including treatment refractory disease
Target Audience:
This activity has been designed to meet the educational needs of medical oncologists, surgeons and other medical professionals involved in the care of patients with breast cancer.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and IMPACt, Inc. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Agenda:
Introduction
Case Presentations:
A 42 year old presents with a 6 month history of a left breast mass and a 3 week history of a new onset right hip pain. PE: 4cm mass UOQ left breast, clinically positive axillary node.
A 56 year old was diagnosed with a T2N1 Stage 2 breast cancer, ER, PR and HER-2 negative, in 2007. She was treated with lumpectomy, axillary dissection, RT, and dose dense ACT. She presents now with weight loss and fatigue and is found to have multiple liver metastases and a small left pleural effusion.
Questions and Answers
Faculty:
Monica Morrow, MD, FACS (Course Director)
Chief, Breast Surgery Service, Anne Burnett Windfohr Chair of Clinical Oncology
Memorial Sloan-Kettering Cancer Center
William J. Gradishar, MD, FACP
Director, Breast Medical Oncology
Professor of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Mary E. Cianfrocca, DO
Assistant Professor of Medicine
Feinberg School of Medicine
Northwestern University
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Monica Morrow, MD
No significant financial relationship with any commercial entity related to this activity
William J. Gradishar, MD
No significant financial relationship with any commercial entity related to this activity
Mary Cianfrocca, DO
Consulting fees: Genentech
Speakers’ Bureau: Genentech, Genomic Health
The following PIM and IMPACt, Inc. clinical content reviewers, Linda Graham, RN; Jan Hixon, RN, Jan Schultz, RN, BSN, MSN, Trace Hutchison, PharmD and Scott McMahon hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity or any amount during the past 12 months.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.